Brief: Lineage Cell Therapeutics Says Kevin L. Cook Would Be Resigning As CFO Effective July 8
July 7 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS INC - ON JULY 5, KEVIN L. COOK
NOTIFIED CO THAT HE WOULD BE RESIGNING AS CHIEF FINANCIAL
OFFICER OF LINEAGE EFFECTIVE JULY 8
* LINEAGE CELL THERAPEUTICS INC - EFFECTIVE JULY 8, BRIAN M.
CULLEY WILL SERVE AS LINEAGE'S INTERIM CHIEF FINANCIAL OFFICER
Source: (https://bit.ly/3nJBG6O)
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million